Literature DB >> 17372612

PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway.

Yan Zhang1, Yi Ba, Chang Liu, Guoxun Sun, Li Ding, Songyuan Gao, Jihui Hao, Zhentao Yu, Junfeng Zhang, Ke Zen, Zhongsheng Tong, Yang Xiang, Chen-Yu Zhang.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator-1 alpha (PGC-1alpha) coactivates multiple transcription factors and regulates several metabolic processes. The current study investigated the role of PGC-1alpha in the induction of apoptosis in human epithelial ovarian cancer cells. The PGC-1alpha mRNA level between human ovaries and human ovarian epithelial tumors was examined by quantitative RT-PCR. Less PGC-1alpha expression was found in the surface epithelium of malignant tumors compared with normal ovaries. Overexpression of PGC-1alpha in human epithelial ovarian cancer cell line Ho-8910 induced cell apoptosis through the coordinated regulation of Bcl-2 and Bax expression. Microarray analyses confirmed that PGC-1alpha dramatically affected the apoptosis-related genes in Ho-8910 cells. Mitochondrial functional assay showed that the induction of apoptosis was through the terminal stage by the release of cytochrome c. Furthermore, PGC-1alpha-induced apoptosis was partially, but not completely, blocked by PPARgamma antagonist (GW9662), and suppression of PPARgamma expression by siRNA also inhibited PGC-1alpha-induced apoptosis in Ho-8910 cells. These data suggested that PGC-1alpha exerted its effect through a PPARgamma-dependent pathway. Our findings indicated that PGC-1alpha was involved in the apoptotic signal transduction pathways and downregulation of PGC-1alpha may be a key point in promoting epithelial ovarian cancer growth and progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372612     DOI: 10.1038/cr.2007.11

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  42 in total

Review 1.  Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility.

Authors:  E H Jeninga; K Schoonjans; J Auwerx
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer.

Authors:  Geoffrey D Girnun
Journal:  Semin Cell Dev Biol       Date:  2012-01-21       Impact factor: 7.727

3.  The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death.

Authors:  Roslyn N Crowder; David T Dicker; Wafik S El-Deiry
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

4.  Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Authors:  Wen Liu; Benjamin H Beck; Kedar S Vaidya; Kevin T Nash; Kyle P Feeley; Scott W Ballinger; Keke M Pounds; Warren L Denning; Anne R Diers; Aimee Landar; Animesh Dhar; Tomoo Iwakuma; Danny R Welch
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

5.  Fine-Tuning of PGC1α Expression Regulates Cardiac Function and Longevity.

Authors:  Xudong Zhu; Weiyan Shen; Ke Yao; Hu Wang; Bo Liu; Tangliang Li; Lijuan Song; Daojun Diao; Genxiang Mao; Ping Huang; Chengtao Li; Hongbo Zhang; Yejun Zou; Yugang Qiu; Yuzheng Zhao; Wengong Wang; Yi Yang; Zeping Hu; Johan Auwerx; Joseph Loscalzo; Yong Zhou; Zhenyu Ju
Journal:  Circ Res       Date:  2019-08-15       Impact factor: 17.367

Review 6.  PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors.

Authors:  Chi Luo; Hans R Widlund; Pere Puigserver
Journal:  Trends Cancer       Date:  2016-10

Review 7.  PGC-1 coactivators in the control of energy metabolism.

Authors:  Chang Liu; Jiandie D Lin
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-02-16       Impact factor: 3.848

Review 8.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

9.  Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.

Authors:  Chandraiah Godugu; Ravi Doddapaneni; Apurva R Patel; Rakesh Singh; Roger Mercer; Mandip Singh
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

10.  Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.

Authors:  Shouwei Han; Jeffrey D Ritzenthaler; Xiaojuan Sun; Ying Zheng; Jesse Roman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-05       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.